Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

Despite the staggering impact of obesity on the Black community, columnist Justice B. Hill argues that the issue has been ...

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...

The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

New Activin R-based medications can emerge as perfect solutions for balancing weight loss and muscle building, making a ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Research shows that people with a certain body shape face a higher risk of serious health problems compared to their ...

Novo Nordisk (NVO) stock slipped after ate-stage trial data for a higher-dose version of its popular obesity therapy, ...